Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

8.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
8.0K
Tumor Progression02:07

Tumor Progression

3.7K
3.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.7K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.2K
6.2K
Development of the Limb Synovial Joints01:07

Development of the Limb Synovial Joints

2.8K
Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
2.8K
Skin Cancer01:30

Skin Cancer

6.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Outcomes and Prognostication of CRTC1::TRIM11 Fusion Cutaneous Tumors.

The American journal of surgical pathology·2026
Same author

Subcutaneous para-umbilical low-grade sarcoma with rare FUS::NFATC4 fusion.

Pathology·2026
Same author

Novel perineurioma-like soft tissue tumour with SETD1A::FOSB fusion.

Pathology·2026
Same author

Genomic Landscape of Myoepithelial Carcinoma Tumors.

Oral diseases·2026
Same author

Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Novel FGL2::PDGFD and TGFBI::PDGFB Fusions Expand the Molecular Spectrum of Dermatofibrosarcoma Protuberans.

Genes, chromosomes & cancer·2026
Same journal

Development and clinical application of a histopathology-based pathological scoring system for IgG4-related disease.

Annals of diagnostic pathology·2026
Same journal

Improved prostate cancer grading by incorporating Gleason pattern quantification, invasive cribriform and intraductal carcinoma in the new QUICC-score.

Annals of diagnostic pathology·2026
Same journal

The long-term postoperative course of an intraosseous spindle cell hemangioma of the calcaneus.

Annals of diagnostic pathology·2026
Same journal

Myoepithelioma-like tumor of the vulvar region shows a quiet genome and heterogeneous detectable mechanisms of SMARCB1 inactivation: Integrated analysis of two cases and review of the literature.

Annals of diagnostic pathology·2026
Same journal

Re-evaluation of "Peptic" duodenitis: A review of 622 consecutive duodenal biopsies.

Annals of diagnostic pathology·2026
Same journal

Unusual morphologic features in molecularly defined high-grade sarcomas of the uterus.

Annals of diagnostic pathology·2026
See all related articles

Related Experiment Video

Updated: Apr 20, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.8K

Synovial sarcoma: defining features and diagnostic evolution.

Khin Thway1, Cyril Fisher1

  • 1Sarcoma Unit, Royal Marsden Hospital, London UK.

Annals of Diagnostic Pathology
|December 3, 2014
PubMed
Summary
This summary is machine-generated.

Synovial sarcoma (SS) is a rare cancer defined by a unique genetic translocation. Accurate diagnosis is crucial for effective treatment and targeted therapies.

Keywords:
GeneticsHistopathologySS18-SSXSYTSynovial sarcomaTLE1Translocation

More Related Videos

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

26.6K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

10.0K

Related Experiment Videos

Last Updated: Apr 20, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.8K
The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

26.6K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

10.0K

Area of Science:

  • Oncology
  • Pathology
  • Genetics

Background:

  • Synovial sarcoma (SS) is a high-grade sarcoma often affecting young adults.
  • It is characterized by a specific SS18-SSX fusion oncogene, making it a translocation-associated sarcoma.
  • SS exhibits diverse morphologic patterns, including biphasic and monophasic types, posing diagnostic challenges.

Purpose of the Study:

  • To review the diagnostic spectrum of synovial sarcoma.
  • To highlight recent immunohistochemical and genetic findings in SS.
  • To discuss the differential diagnosis of SS.

Main Methods:

  • Review of existing literature on synovial sarcoma.
  • Analysis of diagnostic criteria, including morphology, immunohistochemistry, and genetics.
  • Comparison with other neoplasms that may mimic SS.

Main Results:

  • Synovial sarcoma diagnosis can be challenging due to morphologic heterogeneity and variable immunoprofiles.
  • The SS18-SSX translocation is a key diagnostic marker, though not universally detected.
  • Morphologic patterns include biphasic (epithelial and spindle cells) and monophasic (spindle cells with subtle epithelial features).

Conclusions:

  • Accurate diagnosis of synovial sarcoma is clinically important due to its relative chemosensitivity compared to other sarcomas.
  • Early and precise diagnosis facilitates appropriate prognostication and treatment planning.
  • Emerging targeted therapies hold future promise for SS management.